Parliamentary Search

Written question asked by Michael Fabricant (Conservative) on Friday, 19 February 2021, in the House of Commons. It was due for an answer on Tuesday, 23 February 2021. It was answered by Edward Argar (Conservative) on Wednesday, 3 March 2021 on behalf of the Department of Health and Social Care.

Coronavirus: Vaccination

Question

To ask the Secretary of State for Health and Social Care, what support his Department is providing for (a) research on and (b) trials of oral vaccines offering immunity to covid-19.

Answer

Through a joint rolling research call for COVID-19 research between the National Institute for Health Research and UK Research and Innovation, funding of over £500,000 has been committed to a study looking at the safety and immunogenicity of two candidate COVID-19 vaccines administered to the respiratory tract in aerosol form, with an expected end date in August 2021.

In addition, Innovate UK, have been managing the delivery of £75 million of the £110 million Department-funded UK Vaccine Network programme. Nine Departmental projects within this portfolio were repurposed to identify other COVID-19 vaccines solutions. Also, two Innovate UK grants worth over £2.2 million in total, were awarded to Stabilitech, now known as IosBio, to assess its COVD-19 vaccine candidate that has an oral capsule delivery system in animal efficacy studies. This technology is now being tested in participants in clinical trials in South Africa and the United States.

Secondary information

Type
Written question
Reference
154738
Session
2019-21
Related items
Coronavirus: Vaccination
Monday, 15 March 2021
Written questions
House of Commons
Subjects
Research Vaccination Coronavirus
Link
View this Written question on www.parliament.uk